Cargando…
Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain
Hepatitis C virus (HCV) infection remains a global health problem. Previously, the prevalence of NS5A resistance-associated substitutions (RASs) to elbasvir, a new direct-acting antiviral (DAA) against the NS5A viral protein was assessed by our group before its introduction into clinical use in Spai...
Autores principales: | Palladino, Claudia, Ezeonwumelu, Ifeanyi Jude, Mate-Cano, Irene, Borrego, Pedro, Martínez-Román, Paula, Arca-Lafuente, Sonia, Resino, Salvador, Taveira, Nuno, Briz, Verónica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398927/ https://www.ncbi.nlm.nih.gov/pubmed/32747734 http://dx.doi.org/10.1038/s41598-020-69692-7 |
Ejemplares similares
-
Epidemic history of hepatitis C virus genotypes and subtypes in Portugal
por: Palladino, Claudia, et al.
Publicado: (2018) -
Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
por: Palladino, Claudia, et al.
Publicado: (2017) -
Epidemiological Trend of Sepsis in Patients with Hospital Admissions Related to Hepatitis C in Spain (2000–2015): A Nationwide Study
por: Alvaro-Meca, Alejandro, et al.
Publicado: (2020) -
NS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in Spain
por: Jimenez-Sousa, María Ángeles, et al.
Publicado: (2016) -
Phylogeography of hepatitis B virus: The role of Portugal in the early dissemination of HBV worldwide
por: Marcelino, Rute, et al.
Publicado: (2022)